CD44 and cancer: It shows the characteristics of cells undergoing EMT (spindle morphology, reprogramming of epithelial–mesenchymal markers), with acquisition of CSCs markers (CD44+) and is more resistant to chemotherapy than basal-like or luminal cancers [29, 30].